Volume 3, Issue 3

Disease Burden Management & HRQoL

In this issue:

Although therapies that slow disease progression and prevent relapses have improved life for many people with MS, the chronic symptoms (spasticity, fatigue, depression, cognitive dysfunction) continue to increase disability and lower health-related quality of life (HRQoL). How should we be managing these symptoms? What works? What doesn’t? What does the current evidence say?  

Those are some of the questions that Dr. Bardia Nourbakhsh, Assistant Professor of Neurology at the Johns Hopkins School of Medicine, addresses in this issue of eMultipleSclerosis Review. 

Learning objectives:

  • Describe the most common chronic MS symptoms, their prevalence, and their effect on patients’ quality of life. 
  • Discuss the management of fatigue, depression, cognitive dysfunction, and spasticity in patients with MS. 

Author:

Bardia Nourbakhsh, MD
Bardia Nourbakhsh, MD

Assistant Professor of Neurology 
Johns Hopkins School of Medicine 
Baltimore, MD

Program Directors:

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: July 29, 2020
Expiration date: July 28, 2022